Advertisement

News & Opinion

Covering the life sciences inside and out

Most Recent

Respiratory syncytial virus cover-up

By | July 30, 2001

The respiratory syncytial virus has a G glycoprotein similar to the leukocyte chemoattractant Fkn that can facilitate infection and modify the host immune response.

0 Comments

The cyclical nature of potential new antibiotics

By | July 30, 2001

Modified cyclical peptides can form pores in lipid bilayers and could be valuable as broad specificity antibiotics.

0 Comments

Indirectly regulating nitric oxide

By | July 27, 2001

The structure of the enzyme DDAH that controls levels of arginine derivates offers the basis for designing selective indirect inhibitors of NO.

0 Comments

Miscarriages explained by gene variation

By | July 27, 2001

Women who suffer recurrent miscarriages may be carrying a variation in a gene involved in blood vessel function.

0 Comments

Proteome chips

By | July 27, 2001

In the July 26 ScienceXpress, Heng Zhu and colleagues from Yale University describe the construction of a proteome microarray containing approximately 80% of all yeast proteins (ScienceXpress 2001, 10.1126/science.1062191). They built a high-quality collection of 5800 yeast open reading frames (ORFs), representing 93.5% of all yeast genes. Each ORF was fused to a glutathione-S-transferase (GST)-HisX6 tag and expressed in yeast under the inducible GAL1 promoter. Proteins were spotted at high spat

0 Comments

Haematopoietic cell gene therapy with foamy viruses

By | July 26, 2001

Transfer of therapeutic genes into haematopoietic stem cells can potentially cure blood disorders such as X-linked severe combined immunodeficiency. But human stem cells are relatively intractable to the available viral vectors. In August Blood, George Vassilopoulos and colleagues from University of Washington, Seattle, describe a new vector system based on foamy viruses from the spumavirus family that can be used for gene transfer into murine haematopoietic stem cells.Foamy viruses are nonpatho

0 Comments

Neuroferritinopathy

By | July 26, 2001

In the Advance Online issue of Nature Genetics, Andrew Curtis and colleagues from the Institute of Human Genetics in Newcastle, UK, describe a new genetic disease that they have named 'neuroferritinopathy'. The neurological disease is characterized by adult-onset degeneration of the basal ganglia and extrapyramidal dysfunction. Affected individuals live within a 40km radius of the home of the earliest founder, a member of a local family from Cumbria, UK. Curtis et al. performed linkage analysis

0 Comments

Real-time study provides insight into human pain process

By | July 26, 2001

Observation of the brain's biochemical response to chronic pain is enabling the natural painkilling mechanisms of the body to be understood in greater detail.

0 Comments

Reduced IDX-1 can lead to type 2 diabetes

By | July 26, 2001

cells of the elderly can be enough to induce metabolic dysfunction and type 2 diabetes.

0 Comments

Creating embryos without sperm

By | July 25, 2001

The announcement that murine embryos have been created without fertilisation by sperm nuclei has opened an important ethical and scientific debate.

0 Comments

Advertisement
BD Bioscience
BD Bioscience

Popular Now

  1. Antibody Maker Loses License Over Animal Welfare Violations
  2. ORI: Researcher Faked Dozens of Experiments
    The Nutshell ORI: Researcher Faked Dozens of Experiments

    A former scientist at the University of Michigan and the University of Chicago made up more than 70 experiments on heart cells, according to the Office of Research Integrity.

  3. Exploring Emotional Contagion
  4. Immune Defect Detected in Knockout Mice
Advertisement
Diagenode
Diagenode
Advertisement
LabX
LabX
Biosearch Technologies
illumina Corporate
illumina Corporate